$2.38
-0.19-7.39%
At close: -
$2.18
-0.20-8.40%
After Hours: 7:53 PM EDT
Comments
Loading...
Unity Biotechnology (NASDAQ:UBX) Stock, Earnings Estimates, EPS, And Revenue
Unity Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 14
EPS Estimate
$-0.400
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Unity Biotechnology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Unity Biotechnology (UBX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $-0.38 | $-0.41 | 7.32 % |
| Q2 | 2024-08-06 | $-0.31 | $-0.46 | 32.6 % |
| Q1 | 2024-05-14 | $-0.34 | $-0.48 | 29.2 % |
| Q4 | 2024-04-15 | $-0.28 | $-0.72 | 61.1 % |
Unity Biotechnology (UBX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Unity Biotechnology (NASDAQ:UBX) reporting earnings?
Unity Biotechnology (UBX) is scheduled to report earnings on April 14, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
What were the latest earnings per share (EPS) for Unity Biotechnology (NASDAQ:UBX)?
The Actual EPS was $-0.38, which beat the estimate of $-0.41.
What were Unity Biotechnology’s (NASDAQ:UBX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.